Management of Hypertension, Obesity, Lipids, and Diabetes with Glucagon-like Peptide 1 Receptor Agonists
Hyperglycemia is considered one of the main risk factors for the development of cardiovascular diseases, and the situation becomes worse if the condition is associated with uncontrolled hypertension, dyslipidemia, and overweight or obesity. Since the first glucagon-like peptide 1 receptor agonist (G...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Schriftenreihe: | International Journal of Diabetes and Technology |
| Schlagworte: | |
| Online-Zugang: | https://journals.lww.com/10.4103/ijdt.ijdt_11_24 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|